Bone marrow progenitor cells

Bone marrow progenitor cells represent a heterogeneous population of stem and progenitor cells residing within the bone marrow that possess the ability to differentiate into various cell types including osteoblasts, chondrocytes, stromal cells, and hematopoietic cells. These cells include mesenchymal stem cells (MSCs) that are positioned in perivascular locations and express key factors like CXCL12 and stem cell factor to support hematopoietic cell retention. They play crucial roles in skeletal development, bone repair, and tissue maintenance through their multipotent differentiation capabilities. In skeletal development, these cells transition from multipotent stem cells in mesenchymal condensations to more specialized tissue-specific stem cells. The cells demonstrate osteogenic, osteoinductive properties and can be used therapeutically in conditions like osteogenesis imperfecta, where allogeneic bone marrow-derived mesenchymal cells can engraft in bone and differentiate into functional osteoblasts. Multiple distinct types of these progenitor cells collaborate to establish and maintain the skeletal system network, with different populations expressing specific markers like Gremlin 1 for osteo-chondro-reticular stem cells and Gli1 for metaphyseal mesenchymal progenitors.

Other names

Mesenchymal stem cellsMSCsSkeletal stem cellsSkeletal progenitor cellsBone marrow stromal cellsHematopoietic progenitor cellsHPCsMesenchymal progenitor cellsOsteo-chondro-reticular stem cellsOCR stem cellsMetaphyseal mesenchymal progenitorsMMPs

The mechanism of action for therapies involving bone marrow progenitor cells includes cell replacement therapy, tissue regeneration, differentiation into osteoblasts and other cell types, and enhancement of bone marrow transplantation effects.